Xu, Richard Huan https://orcid.org/0000-0002-4720-5172
Wong, Eliza Lai-yi
Luo, Nan
Norman, Richard
Lehmann, Jens
Holzner, Bernhard
King, Madeleine T.
Kemmler, Georg
,
Funding for this research was provided by:
the European Organisation for Research and Treatment of Cancer Quality of Life Group (001/2018)
Article History
Received: 5 October 2022
Accepted: 11 September 2023
First Online: 28 September 2023
Declarations
:
: RX, EW, NL, RN, BH, and HT has nothing to disclose. JL and GK reports grants from EORTC Quality of Life Group during the conduct of the study. MK reports grants from the Australian National Health and Medical Research Council (NHMRC Project Grant 632662, to develop the QLU-C10D descriptive system and valuation methods used in the current study) and from the EORTC QOL Group for the conduct of the current study.
: The study was approved by the Ethics Committee, Hong Kong Polytechnic University, with approval number HSEARS20220523001.
: Informed consent was collected from all participants.